lorazepam has been researched along with Cancer of Pituitary in 2 studies
Lorazepam: A benzodiazepine used as an anti-anxiety agent with few side effects. It also has hypnotic, anticonvulsant, and considerable sedative properties and has been proposed as a preanesthetic agent.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Massengale, J | 1 |
| Tafti, BA | 1 |
| Large, L | 1 |
| Skirboll, S | 1 |
| Kragie, L | 1 |
| Doyle, D | 1 |
2 other studies available for lorazepam and Cancer of Pituitary
| Article | Year |
|---|---|
Reversal of preoperative catatonic state by surgical resection of an adult-onset craniopharyngioma: case report and review of the literature.
Topics: Brain; Catatonia; Craniopharyngioma; Hormones; Humans; Hypnotics and Sedatives; Lorazepam; Male; Mid | 2009 |
Benzodiazepines inhibit temperature-dependent L-[125I]triiodothyronine accumulation into human liver, human neuroblast, and rat pituitary cell lines.
Topics: Adenoma; Animals; Anti-Anxiety Agents; Benzodiazepines; Benzodiazepinones; Cell Line; Convulsants; D | 1992 |